These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 22292598)

  • 1. The role of nebulized therapy in the management of COPD: evidence and recommendations.
    Dhand R; Dolovich M; Chipps B; Myers TR; Restrepo R; Farrar JR
    COPD; 2012 Feb; 9(1):58-72. PubMed ID: 22292598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhalatory therapy training: a priority challenge for the physician.
    Melani AS
    Acta Biomed; 2007 Dec; 78(3):233-45. PubMed ID: 18330086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nebulized Therapies in COPD: Past, Present, and the Future.
    Barjaktarevic IZ; Milstone AP
    Int J Chron Obstruct Pulmon Dis; 2020; 15():1665-1677. PubMed ID: 32764912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD.
    Brashier B; Dhembare P; Jantikar A; Mahadik P; Gokhale P; Gogtay JA; Salvi SS
    Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors guiding the choice of delivery device for inhaled corticosteroids in the long-term management of stable asthma and COPD: focus on budesonide.
    Thorsson L; Geller D
    Respir Med; 2005 Jul; 99(7):836-49. PubMed ID: 15939245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of nebulized drug delivery in COPD.
    Tashkin DP
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2585-2596. PubMed ID: 27799757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The importance of inhaler devices: the choice of inhaler device may lead to suboptimal adherence in COPD patients.
    Darbà J; Ramírez G; Sicras A; Francoli P; Torvinen S; Sánchez-de la Rosa R
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2335-45. PubMed ID: 26604733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of inhaler devices in the management of airway disease.
    Virchow JC; Crompton GK; Dal Negro R; Pedersen S; Magnan A; Seidenberg J; Barnes PJ
    Respir Med; 2008 Jan; 102(1):10-9. PubMed ID: 17923402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of pressurized metered dose inhalers in patients with chronic obstructive pulmonary disease: review of evidence.
    Aggarwal B; Gogtay J
    Expert Rev Respir Med; 2014 Jun; 8(3):349-56. PubMed ID: 24802511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Customizing inhaled therapy to meet the needs of COPD patients.
    Fromer L; Goodwin E; Walsh J
    Postgrad Med; 2010 Mar; 122(2):83-93. PubMed ID: 20203459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing clinical features of the nebulizer, metered-dose inhaler, and dry powder inhaler.
    Geller DE
    Respir Care; 2005 Oct; 50(10):1313-21; discussion 1321-2. PubMed ID: 16185367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novolizer: how does it fit into inhalation therapy?
    Magnussen H
    Curr Med Res Opin; 2005; 21 Suppl 4():S39-46; discussion S47. PubMed ID: 16138944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing maintenance therapy for chronic obstructive pulmonary disease: strategies for improving patient-centered outcomes.
    Hanania NA
    Clin Ther; 2007 Oct; 29(10):2121-33. PubMed ID: 18042470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Respimat®, first Soft Mist™ inhaler: new perspectives in the management of COPD].
    Henriet AC; Marchand-Adam S; Mankikian J; Diot P
    Rev Mal Respir; 2010 Dec; 27(10):1141-9. PubMed ID: 21163393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and Management of Chronic Obstructive Pulmonary Disease in the Gulf Countries with a Focus on Inhaled Pharmacotherapy.
    Tashkin DP; Barjaktarevic I; Gomez-Seco J; Behbehani NH; Koltun A; Siddiqui UA
    J Aerosol Med Pulm Drug Deliv; 2024 Aug; 37(4):189-201. PubMed ID: 38813999
    [No Abstract]   [Full Text] [Related]  

  • 16. Innovations to achieve excellence in COPD diagnosis and treatment in primary care.
    Fromer L; Barnes T; Garvey C; Ortiz G; Saver DF; Yawn B
    Postgrad Med; 2010 Sep; 122(5):150-64. PubMed ID: 20861599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhalation therapy with metered-dose inhalers and dry powder inhalers in mechanically ventilated patients.
    Dhand R
    Respir Care; 2005 Oct; 50(10):1331-4; discussion 1344-5. PubMed ID: 16185369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhaler devices for patients with COPD.
    Fink JB; Colice GL; Hodder R
    COPD; 2013 Aug; 10(4):523-35. PubMed ID: 23537191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaler device selection: special considerations in elderly patients with chronic obstructive pulmonary disease.
    Barrons R; Pegram A; Borries A
    Am J Health Syst Pharm; 2011 Jul; 68(13):1221-32. PubMed ID: 21690428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Handling of and preferences for available dry powder inhaler systems by patients with asthma and COPD.
    Schulte M; Osseiran K; Betz R; Wencker M; Brand P; Meyer T; Haidl P
    J Aerosol Med Pulm Drug Deliv; 2008 Dec; 21(4):321-8. PubMed ID: 18823257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.